Hologic Inc (HOLX)
Return on equity (ROE)
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 515,100 | 456,000 | 484,100 | 753,000 | 990,200 | 1,302,000 | 1,512,100 | 1,551,800 | 1,715,500 | 1,869,700 | 2,034,400 | 1,902,700 | 1,378,100 | 1,110,500 | 493,500 | 451,000 | 83,600 | -203,600 | -29,600 | -10,600 |
| Total stockholders’ equity | US$ in thousands | 4,653,800 | 5,016,900 | 5,182,000 | 5,300,800 | 5,092,500 | 4,876,200 | 4,997,900 | 4,792,700 | 4,519,100 | 4,218,600 | 3,877,100 | 3,794,400 | 3,267,900 | 2,705,200 | 2,255,100 | 2,086,100 | 2,250,800 | 2,115,700 | 2,216,500 | 2,159,800 |
| ROE | 11.07% | 9.09% | 9.34% | 14.21% | 19.44% | 26.70% | 30.25% | 32.38% | 37.96% | 44.32% | 52.47% | 50.14% | 42.17% | 41.05% | 21.88% | 21.62% | 3.71% | -9.62% | -1.34% | -0.49% |
December 31, 2023 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $515,100K ÷ $4,653,800K
= 11.07%
The return on equity (ROE) of Hologic Inc has shown fluctuations over the past five years.
From December 2019 to December 2020, the ROE increased from 3.71% to 42.17%, reflecting a significant improvement in the company's profitability and efficiency in generating returns for shareholders. The trend continued positively into the first quarter of 2021, reaching 50.14%, indicating a strong performance in terms of utilizing shareholder equity to generate profits.
However, the ROE declined in the second and third quarters of 2021, dropping to 44.32% and 37.96% respectively. Despite these decreases, the values remained relatively high, indicating that the company was still effectively leveraging its equity to generate profits.
In the fourth quarter of 2021, the ROE further decreased to 32.38%, and this downward trend continued into 2022, with values of 30.25% and 26.70% in the first and second quarters respectively. The ROE dropped to 19.44% in the third quarter of 2022, reflecting a significant decline in the company's ability to generate returns for shareholders from equity.
The trend reversed in the fourth quarter of 2022, as the ROE increased to 14.21% and further improved to 9.34% in the first quarter of 2023. The ROE rose to 9.09% in the second quarter of 2023 and continued to increase to 11.07% by the end of December 2023.
Overall, the performance of Hologic Inc, as measured by its return on equity, has shown variability over the past five years. Despite fluctuations, the company has generally exhibited a solid ability to generate profits from shareholder equity, with some periods of stronger performance and others with lower profitability levels.
Peer comparison
Dec 31, 2023